CFTR and cystic fibrosis: Different studies have utilized viral vectors for CF, most notably the work of Wagner et al. that, in 1998, successfully restored CFTR function in clinical trials by delivery of AAV serotype 2-CFTR into maxillary sinuses [81,82].